G. Lisboa-Neto

Resistance Mutations are Rare among Protease Inhibitor Treatment-Naive Hepatitis C Genotype-1 Patients with or without HIV Coinfection

F. Carrilho, M. Gomes-Gouvêa, M. V. Alvarado-Mora, 2015, Antiviral therapy.

Characteristics of a hepatitis C patient cohort at a specialized tertiary care facility: Identifying criteria to improve the allocation of public health resources

S. Witkin, M. Mendes-Corrêa, A. C. Nastri, 2019, Clinics.

Prevalence of naturally occurring NS5A resistance-associated substitutions in patients infected with hepatitis C virus subtype 1a, 1b, and 3a, co-infected or not with HIV in Brazil

F. Carrilho, M. Mendes-Corrêa, J. R. Pinho, 2017, BMC Infectious Diseases.

Serological and molecular markers of hepatitis E virus infection in HIV-infected patients in Brazil

F. Carrilho, J. Pinho, M. Gomes-Gouvêa, 2017, Archives of Virology.

Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV

F. Carrilho, M. Gomes-Gouvêa, M. Mendes-Corrêa, 2016, Archives of Virology.

Effectiveness of direct-acting antivirals for hepatitis C virus infection in hepatitis C/HIV coinfected individuals

S. Witkin, J. Pinho, M. Mendes-Corrêa, 2020, Medicine.